1. Pink Sheet

Pandemic Accelerates US FDA’s Use Of Real-World Data From Clinical Trial Design To Supply Chain

 
• By Brenda Sandburg

FDA’s Amy Abernethy describes how agency’s use of real-world data has evolved in response to COVID-19 and the ‘a-ha’ moment of leveraging different data sources to understand the coronavirus. Takeda R&D President Andrew Plump notes difficulties with platform trials and limitations on data sharing.

real world data
FDA is using real-world data to respond to COVID-19 pandemic • Source: Shutterstock

The US Food and Drug Administration has advanced the use of real-world data to tackle the COVID-19 pandemic, using it to understand the disease, plan clinical trials, and manage the medical product supply chain to prevent shortages.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Real-World Evidence

More from Clinical Trials